Kenneth Galbraith - Chair & CEO, Director at Zymeworks Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chair & CEO, Director
Issuer Symbol
ZYME on Nasdaq
All Insider Reports
All Insider Reports

Kenneth Galbraith - trading volume in the past year for Zymeworks Inc.

Holdings reported by Kenneth Galbraith for Zymeworks Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 226,842 $5,143,302 $22.67 12 Jan 2026 Direct
Restricted Stock Unit 144,000 $2,865,427 $14.92 12 Jan 2026 Direct Common Stock
Performance Stock Unit 222,000 12 Jan 2026 Direct Common Stock
Stock Option (Right to Buy) 216,000 12 Jan 2026 Direct Common Stock

Transactions reported by Kenneth Galbraith for Zymeworks Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.